A detailed history of Bit Capital Gmb H transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 241,056 shares of HOWL stock, worth $323,015. This represents 0.03% of its overall portfolio holdings.

Number of Shares
241,056
Previous 241,056 -0.0%
Holding current value
$323,015
Previous $511 Million 30.19%
% of portfolio
0.03%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 12, 2025

BUY
$1.71 - $2.95 $13,143 - $22,673
7,686 Added 3.29%
241,056 $511 Million
Q2 2024

Feb 12, 2025

BUY
$2.34 - $6.75 $546,085 - $1.58 Million
233,370 New
233,370 $569 Million

Others Institutions Holding HOWL

About Werewolf Therapeutics, Inc.


  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $39.6M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.